426 results on '"Leni R"'
Search Results
102. Assessing the need for systematic biopsies in addition to targeted biopsies according to the volume of the index lesion diagnosed at mpMRI. results from a large, multi-institutional database
103. Temporal trend analyses of stage, surgical technique, oncological treatment, and post-operative outcomes in a large cohort of patients undergoing radical cystectomy at a referral institution
104. The detection of a PI-RADS 4–5 lesion at multiparametric MRI before confirmatory biopsy is the strongest predictor of disease progression among men with low-risk prostate cancer included in an active surveillance prospective protocol
105. What is the definition of misclassification in patients with grade group 2 prostate cancer eligible for active surveillance and diagnosed with MRI targeted biopsy? a multi-institutional analysis with pathological confirmation
106. Saturation of the MPMRI lesion is not necessary to minimize the risk of missing clinically significant prostate cancer at targeted biopsy. Analysis of a large, multi-institutional series
107. Preoperative frailty status is a predictor of 90-days readmission in radical cystectomy candidates
108. Identifying the optimal clinical setting for the use of multiparametric magnetic resonance imaging of the prostate as local staging tool in men candidate to radical prostatectomy. Results from a multi-institutional series
109. The obesity paradox in metastatic castration resistant prostate cancer
110. Should we routinely recommend a central review of magnetic resonance imaging of the prostate in men with positive mp-MRI? Implication for targeted biopsies
111. The learning curve of mpMRI targeted biopsy for the detection of clinically significant prostate cancer is related to the characteristics of the index lesion
112. Knock out of neuronal nitric oxide synthase exacerbates intestinal ischemia/reperfusion injury in mice
113. Damaging effects of ischemia/reperfusion on intestinal muscle
114. The reactions of specific neuron types to intestinal ischemia in the guinea pig enteric nervous system
115. High- and medium-molecular-weight neurofilament proteins define specific neuron types in the guinea-pig enteric nervous system
116. Gut Microbiome Composition Remains Stable in Individuals with Diabetes-Related Early to Late Stage Chronic Kidney Disease
117. Differential level of RXFP3 expression in dopaminergic neurons within the arcuate nucleus, dorsomedial hypothalamus and ventral tegmental area of RXFP3-Cre/tdTomato mice
118. Development of novel criteria to identify the optimal candidates for active surveillance among men with low-risk prostate cancer and a positive family history. Results from a large, single institution series
119. Positive predictive value of mpmri in men under active surveillance: Can the biopsy history influence radiological assessment?
120. How to follow patients with negative targeted prostate biopsy but positive multi-parametric MRI? Results from a large, single institution series
121. The role of a digital psychological support for prostate cancer patients managed by a multidisciplinary disease unit: Initial experience from a referral center
122. 68Ga-PSMA PET/CT for Recurrent Prostate Cancer after Radical Prostatectomy: What’s next? Analysis from a single, high volume tertiary referral center
123. Assessing in-hospital morbidity after urethroplasty using the EAU quality criteria for standardized reporting
124. Impact of perioperative complications on length of hospitalizations, readmission rate and treatment failure after urethroplasty
125. Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor
126. VJY08 - Rectovesical fistula after radical prostatectomy: robot-assisted repair with direct suture and omental-flap interposition
127. The gut as a sensory organ
128. Differential Level of RXFP3 Expression in Dopaminergic Neurons Within the Arcuate Nucleus, Dorsomedial Hypothalamus and Ventral Tegmental Area of RXFP3-Cre/tdTomato Mice
129. Focal therapy for prostate cancer: do apical lesions correlate with worse outcomes?
130. Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data
131. Age and Gleason score upgrading between prostate biopsy and radical prostatectomy. Is this still true in the mp-MRI era?
132. Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance: Results from a single institution series
133. Unravelled facets of milk derived opioid peptides: a focus on gut physiology, fractures and obesity
134. SC137 - Histological variants of prostate cancer are under-reported in prostate biopsies assessed outside tertiary referral centers. a plea for biopsy review for optimal patient management
135. SC128 - Acute kidney injury and its duration in patients treated with radical cystectomy in the enhanced recovery after surgery era: optimizing the selection of patients for restrictive fluid therapy
136. SC96 - Delaying post-operative radiation therapy after radical prostatectomy is associated with increased functional outcomes: results from a large single, referral center series
137. SC90 - Not all adverse pathology features are equal: identifying optimal candidates for adjuvant radiotherapy among patients with adverse pathology at radical prostatectomy
138. SC33 - The impact of variant histology on the probability of lymph node involvement at imaging: CT scan vs FDG PET
139. SC34 - The role of FDG PET in the staging of bladder cancer patients candidate for radical cystectomy
140. SC15 - Oncologic surveillance intensity for variant histology versus pure urothelial carcinoma of the bladder after radical cystectomy
141. SC12 - The impact of histological variants on the performance characteristics of 68Ga-PSMA PET/CT in the primary and recurrent setting
142. SC10 - Drop-out rates from active surveillance for disease progression remain consistent and not negligible over time. A plea for long-term assessment based on a large, prospectively collected active surveillance cohort
143. SC8 - Reliability of 68Ga-PSMA PET/CT in assessing real nodal burden in men with cN1 disease: clinical implications for patient counselling and multi-modal treatments
144. SC4 - Detection of clinically significant prostate cancer in mpMRI visible lesions: size matters. Results from a large, two-institutional series
145. SC3 - Comparative analyses of micro-ultrasound versus MRI-targeted biopsy for the diagnosis of clinically significant prostate cancer. Preliminary results from the prospective us-mirror trial
146. SC1 - Oncological outcomes, patterns of recurrence and impact of competing causes of mortality in clinically node-positive prostate cancer patients treated with radical prostatectomy
147. VE31 - 99m-Technetium-PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing with radical prostatectomy and extended pelvic lymph node dissection
148. SC267 - 99M-technetium-psma radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection: a phase 2 prospective, single-institution study
149. SC275 - The risk of recurrence in cN1 prostate cancer patients treated with radical prostatectomy varies according to the type preoperative staging. a comparison between 68ga-PSMA-PET versus conventional imaging in a large, multi-institutional study
150. SC268 - Does centralized revision of prostate biopsy impact on active surveillance outcomes? results from a single, high-volume institution series
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.